Senior Director, Evidence Generation & Clinical Strategy

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and Med Tech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more at

As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

Job Function:
Marketing
Job Sub Function:
Strategic Marketing
Job Category:
People Leader
All Job Posting Locations:
Irvine, California, United States of America
Job Description:

Johnson & Johnson is currently seeking the best talent for a Senior Director, Evidence Generation & Clinical Strategy to join our Med Tech Electrophysiology organization. This position will be based in Irvine, CA.

The Senior Director, Evidence Generation & Clinical Strategy will lead the Electrophysiology (EP) Evidence Generation Strategy (EGS) process, ensuring evidence generation priorities are aligned to business strategy, portfolio objectives, clinical needs, regulatory requirements, and market access opportunities. The role serves as the primary orchestrator of the annual and quarterly evidence planning process, collecting, consolidating, and prioritizing evidence needs from business partners across Global Strategic Marketing Upstream and Downstream, Regional Marketing, Clinical Research, Medical Affairs, Regulatory Affairs, Health Economics & Market Access, Strategy, and R&D.

This role partners closely with Clinical Science & External Research (CSER).

This highly strategic leadership role drives cross-functional alignment on evidence generation priorities and translates commercial, clinical, and competitive insights into an actionable evidence agenda. The position acts as the primary bridge between business partners and CSER, ensuring evidence plans are aligned with portfolio priorities, launch readiness, long-range financial planning, and annual business planning cycles.

This candidate should possess deep knowledge of EP therapies, clinical evidence requirements, product strategy, portfolio management, and regulatory pathways, with proven ability to influence senior leaders and drive alignment across a complex organization. Additional responsibilities will include:

• Own and lead the annual Evidence Generation Strategy (EGS) process integrated with the Business Planning cycle.
• Lead structured evidence needs collection across GSM, Regional Marketing, Clinical Research, Medical Affairs, Regulatory Affairs, HEMA, Strategy, R&D, and CSER partners.
• Collect, organize, and synthesize evidence requests into a unified portfolio of strategic evidence needs across products, therapies, regions, and customer segments.
• Design and facilitate evidence prioritization processes that evaluate business impact, timing, customer value, regulatory significance, and strategic importance.
• Deliver prioritized evidence generation recommendations and investment proposals to senior leadership.
• Partner with CSER to translate prioritized evidence needs into integrated evidence plans and study portfolios.
• Serve as business owner for evidence governance, request templates, intake processes, prioritization criteria, and business partner alignment mechanisms.
• Lead quarterly reviews of emerging evidence needs and facilitate pathways for urgent requests requiring leadership review.
• Ensure evidence priorities align with LRFP objectives, new product introductions, indication expansion strategies, and portfolio priorities.
• Provide regular reporting to senior leadership regarding evidence priorities, plan status, risks, and expected data availability.
• Partner with Clinical and Medical Affairs teams to shape clinical study strategy and identify endpoints aligned with strategic business and market needs.
• Translate clinical evidence, trial data, and real-world outcomes into strategic insights that inform portfolio and commercialization decisions.
• Collaborate with Regulatory and Medical Affairs to ensure evidence plans support future claims, market access, and regulatory requirements.
• Serve as an internal authority on EP trends, guidelines, ablation technologies, mapping systems, and competitive evidence strategies.
• Help own the strategy for white papers, KOL engagement, conference planning, and thought leadership activities supporting long-term evidence objectives.
• Engage with electrophysiologists, key opinion leaders, professional societies, and external partners to identify emerging evidence opportunities and gaps.
• Contribute to publication strategies, podium presence, and major EP conferences…